Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-01 Sale(A) | 2024-02-05 9:16 pm | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 4,993 | $15.78 | $78,790 | 23,414 (Direct) | View |
| 2024-01-31 Sale | 2024-02-02 7:12 pm | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 4,993 | $15.74 | $78,590 | 55,748 (Direct) | View |
| 2023-08-31 Sale | 2023-09-05 4:28 pm | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 3,800 | $18.01 | $68,438 | 18,407 (Direct) | View |
| 2023-01-31 Sale | 2023-02-02 1:04 pm | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 1,636 | $10.12 | $16,556 | 79,707 (Direct) | View |
| 2022-08-31 Sale | 2022-09-02 11:40 am | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 3,606 | $7.21 | $25,999 | 20,510 (Direct) | View |
| 2022-01-31 Sale | 2022-02-02 4:35 pm | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 414 | $7.58 | $3,138 | 46,616 (Direct) | View |
| 2021-11-30 Sale | 2021-12-02 1:16 pm | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 3,803 | $12.03 | $45,750 | 23,697 (Direct) | View |
| 2021-05-17 Purchase | 2021-05-18 11:35 am | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 2,500 | $15.71 | $39,275 | 2,500 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-31 Option Award | 2024-02-02 7:12 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 16,500 | $0 | 55,748 (Direct) | View |
| 2024-01-31 Exercise | 2024-02-02 7:12 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 10,000 | $0 | 55,748 (Direct) | View |
| 2023-09-07 Option Award | 2023-09-08 3:41 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 10,000 | $0 | 10,000 (Direct) | View |
| 2023-08-31 Exercise | 2023-09-05 4:28 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 8,334 | $0 | 18,407 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 1:04 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 60,000 | $0 | 79,707 (Direct) | View |
| 2023-01-31 Exercise | 2023-02-02 1:04 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 3,333 | $0 | 79,707 (Direct) | View |
| 2022-08-31 Exercise | 2022-09-02 11:40 am | N/A N/A | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 8,333 | $0 | 20,510 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-02 4:35 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 37,500 | $0 | 46,616 (Direct) | View |
| 2022-01-31 Exercise | 2022-02-02 4:35 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 833 | $0 | 46,616 (Direct) | View |
| 2021-11-30 Exercise | 2021-12-02 1:16 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 8,333 | $0 | 23,697 (Direct) | View |
| 2021-06-05 Option Award | 2021-06-08 2:33 pm | N/A 2031-05-31 | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-01-31 Option Award | 2021-02-02 3:55 pm | N/A 2031-01-30 | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 10,500 | $0 | 10,500 (Direct) | View |
| 2020-10-01 Option Award(A) | 2020-10-05 4:35 pm | N/A 2030-09-30 | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 85,000 | $0 | 85,000 (Direct) | View |
| 2020-09-09 Option Award | 2020-09-10 12:14 pm | N/A 2030-09-08 | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 85,000 | $0 | 85,000 (Direct) | View |